Cargando…

Prevalence and associated factors of premature discontinuation of antiplatelet therapy after ischemic stroke: a nationwide population-based study

BACKGROUND: We tried to evaluate the prevalence of premature discontinuation of antiplatelets and its affecting factors after ischemic stroke using large-sized representative national claims data. METHODS: Patients aged 20 years or older with newly confirmed ischemic stroke who started aspirin or cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seung Jae, Kwon, Oh Deog, Choi, Ho Chun, Lee, Eung-Joon, Cho, BeLong, Yoon, Dae Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431917/ https://www.ncbi.nlm.nih.gov/pubmed/34507550 http://dx.doi.org/10.1186/s12883-021-02384-5

Ejemplares similares

Effect of antiplatelet persistence on long-term mortality and predictors of non-persistence in ischemic stroke patients 75 years and older: a nationwide cohort study
por: Kim, Seung Jae, et al.
Publicado: (2021)

Non-persistence with anti-platelet therapy and long-term mortality after ischemic stroke: A nationwide study
por: Kim, Seung Jae, et al.
Publicado: (2021)

Prevalence, awareness, and treatment of depression among community-dwelling stroke survivors in Korea
por: Lee, Eung-Joon, et al.
Publicado: (2022)

Effects of combination drugs on antihypertensive medication adherence in a real-world setting: a Korean Nationwide Study
por: Kim, Seung Jae, et al.
Publicado: (2019)

Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke
por: Kim, Tae Jung, et al.
Publicado: (2023)

Influenza Vaccination Status and Its Affecting Factors among Stroke Survivors: Findings from the Korea National Health and Nutrition Examination Survey
por: Lee, Eung-Joon, et al.
Publicado: (2021)

Impact of number of medications and age on adherence to antihypertensive medications: A nationwide population-based study
por: Kim, Seung Jae, et al.
Publicado: (2019)

Antiplatelet Use in Ischemic Stroke
por: Kamarova, Marharyta, et al.
Publicado: (2022)

Impact of onset-to-door time on outcomes and factors associated with late hospital arrival in patients with acute ischemic stroke
por: Lee, Eung-Joon, et al.
Publicado: (2021)

Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long‐Term Outcomes
por: Kinlay, Scott, et al.
Publicado: (2021)

Antiplatelet regimens for Asian patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
por: Jung, Seung Jin, et al.
Publicado: (2021)

Clopidogrel Resistance in Patients With Stroke Recurrence Under Single or Dual Antiplatelet Treatment
por: Kang, Hyun Goo, et al.
Publicado: (2021)

Anticoagulation versus Antiplatelet Therapy after Ischemic Stroke in the Patients with Atrial Fibrillation and Cerebral Microbleeds
por: Choi, Kang-Ho, et al.
Publicado: (2021)

Antiplatelet regimens after ischemic stroke or transient ischemic attack: a systematic review and updated network meta-analysis
por: Jung, Seung Jin, et al.
Publicado: (2022)

Beyond antiplatelets: The role of glycoprotein VI in ischemic stroke
por: Induruwa, Isuru, et al.
Publicado: (2016)

Cold Snare Polypectomy in Patients Taking Dual Antiplatelet Therapy: A Randomized Trial of Discontinuation of Thienopyridines
por: Won Ma, Dae, et al.
Publicado: (2019)

Elevated neutrophil to lymphocyte ratio and ischemic stroke risk in generally healthy adults
por: Suh, Beomseok, et al.
Publicado: (2017)

Impact of a family history of cardiovascular disease on prevalence, awareness, treatment, control of dyslipidemia, and healthy behaviors: Findings from the Korea National Health and Nutrition Examination Survey
por: Kim, Seung Jae, et al.
Publicado: (2021)

Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke
por: Zhong, Jie, et al.
Publicado: (2023)

Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome
por: Kang, Min Gyu, et al.
Publicado: (2022)

Comparative effectiveness of combined antiplatelet treatments in acute minor ischaemic stroke
por: Kim, Shina, et al.
Publicado: (2021)

Antiplatelet and Antithrombotic Effects of Epimedium koreanum Nakai
por: Irfan, Muhammad, et al.
Publicado: (2021)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Implications of the Antiplatelet Therapy Gap Left With Discontinuation of Prasugrel in Canada
por: Lordkipanidzé, Marie, et al.
Publicado: (2020)

Advances in Our Understanding of “Resistance” to Antiplatelet Agents for Prevention of Ischemic Stroke
por: Gorelick, Philip B., et al.
Publicado: (2013)

Antiplatelet therapy may be safe in ischemic stroke patients with cerebral microbleed
por: Meng, Ningqin, et al.
Publicado: (2020)

Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review
por: Alhazzani, Adel, et al.
Publicado: (2021)

Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke
por: Xian, Ying, et al.
Publicado: (2022)

Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons
por: Hong, Keun-Sik
Publicado: (2014)

Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study
por: Christiansen, Christine Benn, et al.
Publicado: (2015)

In-Hospital and Post-Discharge Recovery after Acute Ischemic Stroke: a Nationwide Multicenter Stroke Registry-base Study
por: Jang, Min Uk, et al.
Publicado: (2019)

Perioperative antiplatelet in elderly patients aged over 70 years treated with proximal femur fracture: continue or discontinue?
por: Jang, Chul-Young, et al.
Publicado: (2019)

Continue or Discontinue Dual Antiplatelet Therapy in Major Surgical or Endoscopic Procedures
por: Cheon, Young Koog
Publicado: (2013)

Antiplatelet Usage Impacts Clot Density in Acute Anterior Circulation Ischemic Stroke
por: Pikija, Slaven, et al.
Publicado: (2016)

Dual or Mono Antiplatelet Therapy for the Prevention of Ischemic Stroke: A Literature Review
por: Anjum, Ibrar, et al.
Publicado: (2018)

Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome
por: Okuma, Hirohisa, et al.
Publicado: (2009)

Premature Cardiac Contractions and Risk of Incident Ischemic Stroke
por: Ofoma, Uchenna, et al.
Publicado: (2012)

Hypertension and Ischemic Stroke After Aflibercept for Retinopathy of Prematurity
por: Bazvand, Fatemeh, et al.
Publicado: (2020)

Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
por: Vališ, Martin, et al.
Publicado: (2021)

Pacemaker lead malpositioning led to subsequent ischemic strokes despite antiplatelet and anticoagulation therapy
por: Rath, Claus, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_clng5e4b52pmfnmqpnt3qgfkpv